TRIALS IN PROGRESS: A PHASE 1B SINGLE-ARM, OPEN-LABEL STUDY OF EMAVUSERTIB IN COMBINATION WITH AZACITIDINE AND VENETOCLAX IN AML PATIENTS IN COMPLETE RESPONSE WITH MRd

Venclexta (venetoclax) - Roche, AbbVie

azacitidine - Generic mfg.

emavusertib (CA-4948) - Curis, Dr. Reddy’s

https://ebmt2024.abstractserver.com/program/#/details/presentations/1636

Adolfo de la Fuente1; Claudio Cerchione2; Sebastian Scholl3; Jan Moritz Middeke4; Gaurav S. Choudhary5; Dora Ferrari5; Reinhard von Roemeling5; Uwe Platzbecker6

Feb 14, 2024